Federal advisory committees are a key component of CDC’s overall strategy to achieve stakeholder and public engagement in its efforts and commitment to improve people’s health. The Federal Advisory Committee Act (P.L. 92-463) provides a mechanism for experts and stakeholders to participate in the decision-making process, offering advice and recommendations to the federal government as members of advisory committees is overseen at the highest levels of government: Congress, the President of the United States, and the General Services Administrator (through authority delegated by the president). At CDC, advisory committee activity is overseen by the Office of the Chief Operating Officer (OCOO)’s Strategic Business Initiatives Unit (SBI).

Currently, federal advisory committees provide advice and recommendations on a broad range of public health issues to help the agency achieve its mission to promote health and quality of life by preventing and controlling disease, injury, and disability. Among the program areas our committees deliberate on are occupational and environmental health, healthcare infection control and clinical laboratory standards, smoking, breast and cervical cancer, HIV, STDs, and tuberculosis, childhood and adult immunizations, and injury prevention and control.

Please see the list of advisory committees below for detailed information.

Page last reviewed: February 3, 2020